{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:27:56Z","timestamp":1725409676343},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"DOI":"10.7759\/cureus.68543","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:16:46Z","timestamp":1725380206000},"source":"Crossref","is-referenced-by-count":0,"title":["Eduardo Slatopolsky: A Pioneer in the Field of Mineral and Bone Disorders in Kidney Disease"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Tinawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.06.001","article-title":"In memoriam: Eduardo Slatopolsky, MD, 1934-2024","volume":"106","author":"Bellorin-Font E","year":"2024","unstructured":"Bellorin-Font E, Rothstein M, Martin KJ. In memoriam: Eduardo Slatopolsky, MD, 1934-2024. Kidney Int. 2024, 106:168-70. 10.1016\/j.kint.2024.06.001","journal-title":"Kidney Int"},{"key":"ref2","unstructured":"Obituary. Eduardo Slatopolsky, MD, FACP. (2024). Accessed: August 25, 2024: https:\/\/internalmedicine.wustl.edu\/obituary-eduardo-slatopolsky-md-facp\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.26502\/aimr.0098","article-title":"Osteoporosis management in patients with chronic kidney disease","volume":"5","author":"Tinawi M","year":"2022","unstructured":"Tinawi M. Osteoporosis management in patients with chronic kidney disease. Arch Intern Med Res. 2022, 5:161-71. 10.26502\/aimr.0098","journal-title":"Arch Intern Med Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe S","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, et al.. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006, 69:1945-53. 10.1038\/sj.ki.5000414","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V891470","article-title":"The pathologic physiology of chronic Bright's disease. An exposition of the \"intact nephron hypothesis\"","volume":"8","author":"Bricker NS","year":"1997","unstructured":"Bricker NS, Morrin PA, Kime SW Jr. The pathologic physiology of chronic Bright's disease. An exposition of the \"intact nephron hypothesis\". J Am Soc Nephrol. 1997, 8:1470-6. 10.1681\/ASN.V891470","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105877","article-title":"Control of phosphate excretion in uremic man","volume":"47","author":"Slatopolsky E","year":"1968","unstructured":"Slatopolsky E, Robson AM, Elkan I, Bricker NS. Control of phosphate excretion in uremic man. J Clin Invest. 1968, 47:1865-74. 10.1172\/JCI105877","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1973.92","article-title":"The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease","volume":"4","author":"Slatopolsky E","year":"1973","unstructured":"Slatopolsky E, Bricker NS. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int. 1973, 4:141-5. 10.1038\/ki.1973.92","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1969.00300150061009","article-title":"Caclium, phosphorus, and bone in renal disease and transplantation","volume":"123","author":"Bricker NS","year":"1969","unstructured":"Bricker NS, Slatopolsky E, Reiss E, Avioli LV. Caclium, phosphorus, and bone in renal disease and transplantation. Arch Intern Med. 1969, 123:543-53.","journal-title":"Arch Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky E","year":"1971","unstructured":"Slatopolsky E, Caglar S, Pennell JP, Taggart DD, Canterbury JM, Reiss E, Bricker NS. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest. 1971, 50:492-9. 10.1172\/JCI106517","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000081668.41546.2b","article-title":"New developments in hyperphosphatemia management","volume":"14","author":"Slatopolsky E","year":"2003","unstructured":"Slatopolsky E. New developments in hyperphosphatemia management. J Am Soc Nephrol. 2003, 14:S297-9. 10.1097\/01.asn.0000081668.41546.2b","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11901115","article-title":"Phosphate toxicity in CKD: the killer among us","volume":"11","author":"Ritter CS","year":"2016","unstructured":"Ritter CS, Slatopolsky E. Phosphate toxicity in CKD: the killer among us. Clin J Am Soc Nephrol. 2016, 11:1088-100. 10.2215\/CJN.11901115","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.12.2206","article-title":"Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function","volume":"17","author":"Ritter CS","year":"2002","unstructured":"Ritter CS, Martin DR, Lu Y, Slatopolsky E, Brown AJ. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Miner Res. 2002, 17:2206-13. 10.1359\/jbmr.2002.17.12.2206","journal-title":"J Bone Miner Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00517.x","article-title":"First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl","volume":"68","author":"Martin KJ","year":"2005","unstructured":"Martin KJ, J\u00fcppner H, Sherrard DJ, et al.. First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int. 2005, 68:1236-43. 10.1111\/j.1523-1755.2005.00517.x","journal-title":"Kidney Int"},{"key":"ref14","article-title":"Current concepts of the metabolism and radioimmunoassay of parathyroid hormone","volume":"99","author":"Slatopolsky E","year":"1982","unstructured":"Slatopolsky E, Martin K, Morrissey J, Hruska K. Current concepts of the metabolism and radioimmunoassay of parathyroid hormone. J Lab Clin Med. 1982, 99:309-16.","journal-title":"J Lab Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF02374904","article-title":"The metabolism and radioimmunoassay of parathyroid hormone","volume":"9","author":"Martin KJ","year":"1991","unstructured":"Martin KJ. The metabolism and radioimmunoassay of parathyroid hormone. J Bone Miner Metab. 1991, 9:31-8. 10.1007\/BF02374904","journal-title":"J Bone Miner Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1972.84","article-title":"On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using \"proportional reduction\" of dietary phosphorus intake","volume":"2","author":"Slatopolsky E","year":"1972","unstructured":"Slatopolsky E, Caglar S, Gradowska L, Canterbury J, Reiss E, Bricker NS. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using \"proportional reduction\" of dietary phosphorus intake. Kidney Int. 1972, 2:147-51. 10.1038\/ki.1972.84","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1990.259.3.F432","article-title":"Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol","volume":"259","author":"Lopez-Hilker S","year":"1990","unstructured":"Lopez-Hilker S, Dusso AS, Rapp NS, Martin KJ, Slatopolsky E. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol. 1990, 259:F432-7. 10.1152\/ajprenal.1990.259.3.F432","journal-title":"Am J Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky E","year":"1996","unstructured":"Slatopolsky E, Finch J, Denda M, et al.. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest. 1996, 97:2534-40. 10.1172\/JCI118701","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1972.6","article-title":"Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease","volume":"1","author":"Slatopolsky E","year":"1972","unstructured":"Slatopolsky E, Rutherford WE, Hoffsten PE, Elkan IO, Butcher HR, Bricker NS. Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease. Kidney Int. 1972, 1:38-46. 10.1038\/ki.1972.6","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(88)80119-7","article-title":"Toxic effects of aluminum in end-stage renal disease: discussion of a case","volume":"12","author":"Coburn JW","year":"1988","unstructured":"Coburn JW, Norris KC, Sherrard DJ, Bia M, Llach F, Alfrey AC, Slatopolsky E. Toxic effects of aluminum in end-stage renal disease: discussion of a case. Am J Kidney Dis. 1988, 12:171-84. 10.1016\/s0272-6386(88)80119-7","journal-title":"Am J Kidney Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607173150304","article-title":"Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis","volume":"315","author":"Slatopolsky E","year":"1986","unstructured":"Slatopolsky E, Weerts C, Lopez-Hilker S, Norwood K, Zink M, Windus D, Delmez J. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med. 1986, 315:157-61. 10.1056\/NEJM198607173150304","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V3196","article-title":"Calcium acetate as a phosphorus binder in hemodialysis patients","volume":"3","author":"Delmez JA","year":"1992","unstructured":"Delmez JA, Tindira CA, Windus DW, Norwood KY, Giles KS, Nighswander TL, Slatopolsky E. Calcium acetate as a phosphorus binder in hemodialysis patients. J Am Soc Nephrol. 1992, 3:96-102. 10.1681\/ASN.V3196","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group","volume":"55","author":"Slatopolsky EA","year":"1999","unstructured":"Slatopolsky EA, Burke SK, Dillon MA. RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group. Kidney Int. 1999, 55:299-307. 10.1046\/j.1523-1755.1999.00240.x","journal-title":"Kidney Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients","volume":"74","author":"Slatopolsky E","year":"1984","unstructured":"Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest. 1984, 74:2136-43. 10.1172\/JCI111639","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V105980","article-title":"Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone","volume":"10","author":"Finch JL","year":"1999","unstructured":"Finch JL, Brown AJ, Slatopolsky E. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone. J Am Soc Nephrol. 1999, 10:980-5. 10.1681\/ASN.V105980","journal-title":"J Am Soc Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V11112088","article-title":"Calcemic activity of 19-Nor-1,25(OH)2D2 decreases with duration of treatment","volume":"11","author":"Brown AJ","year":"2000","unstructured":"Brown AJ, Finch J, Takahashi F, Slatopolsky E. Calcemic activity of 19-Nor-1,25(OH)2D2 decreases with duration of treatment. J Am Soc Nephrol. 2000, 11:2088-94. 10.1681\/ASN.V11112088","journal-title":"J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00386.x","article-title":"Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate","volume":"55","author":"Brown AJ","year":"1999","unstructured":"Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int. 1999, 55:1284-92. 10.1046\/j.1523-1755.1999.00386.x","journal-title":"Kidney Int"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso AS","year":"2005","unstructured":"Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005, 289:F8-28. 10.1152\/ajprenal.00336.2004","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/289354-eduardo-slatopolsky-a-pioneer-in-the-field-of-mineral-and-bone-disorders-in-kidney-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:16:50Z","timestamp":1725380210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/289354-eduardo-slatopolsky-a-pioneer-in-the-field-of-mineral-and-bone-disorders-in-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.68543","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,3]]}}}